GE HealthCare Technologies Past Earnings Performance
Past criteria checks 3/6
GE HealthCare Technologies's earnings have been declining at an average annual rate of -5.3%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 3.9% per year. GE HealthCare Technologies's return on equity is 20.3%, and it has net margins of 8.6%.
Key information
-5.3%
Earnings growth rate
-13.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 3.9% |
| Return on equity | 20.3% |
| Net Margin | 8.6% |
| Next Earnings Update | 13 Feb 2025 |
Recent past performance updates
Recent updates
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
Dec 19With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For
Dec 16
GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
Dec 06From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
Oct 30GE HealthCare: The Image Of More Upside Is Very Real
Sep 18Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?
Sep 05GE HealthCare Q2 Earnings Recap (Rating Downgrade)
Aug 06GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
Jul 07Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09Revenue & Expenses Breakdown
How GE HealthCare Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 19,559 | 1,675 | 3,817 | 1,282 |
| 30 Jun 24 | 19,518 | 1,584 | 3,767 | 1,288 |
| 31 Mar 24 | 19,495 | 1,574 | 3,755 | 1,259 |
| 31 Dec 23 | 19,552 | 1,389 | 3,767 | 1,205 |
| 30 Sep 23 | 19,284 | 1,534 | 3,653 | 1,161 |
| 30 Jun 23 | 19,038 | 1,643 | 3,681 | 1,099 |
| 31 Mar 23 | 18,705 | 1,698 | 3,637 | 1,058 |
| 31 Dec 22 | 18,341 | 1,898 | 3,621 | 1,026 |
| 30 Sep 22 | 17,992 | 1,914 | 3,652 | 980 |
| 30 Jun 22 | 17,720 | 1,929 | 3,660 | 920 |
| 31 Mar 22 | 17,582 | 2,037 | 3,624 | 859 |
| 31 Dec 21 | 17,585 | 2,229 | 3,564 | 816 |
| 31 Dec 20 | 17,164 | 2,007 | 3,241 | 810 |
| 31 Dec 19 | 16,633 | 1,652 | 3,599 | 833 |
Quality Earnings: GEHC has high quality earnings.
Growing Profit Margin: GEHC's current net profit margins (8.6%) are higher than last year (8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GEHC's earnings have declined by 5.3% per year over the past 5 years.
Accelerating Growth: GEHC's earnings growth over the past year (9.2%) exceeds its 5-year average (-5.3% per year).
Earnings vs Industry: GEHC earnings growth over the past year (9.2%) did not outperform the Medical Equipment industry 15%.
Return on Equity
High ROE: Whilst GEHC's Return on Equity (20.3%) is high, this metric is skewed due to their high level of debt.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 00:08 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GE HealthCare Technologies Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Navann Ty Dietschi | BNP Paribas Exane |
| Craig Bijou | BofA Global Research |
| Michael Gorman | BTIG |